Learn More
BACKGROUND The combination of bevacizumab (B) and erlotinib (E) has shown promising clinical outcomes as the first-line treatment of advanced HCC patients. We aimed to evaluate the efficacy and safety of using combination of B + E in treating advanced HCC patients who had failed prior sorafenib treatment. METHODS Eligible advanced HCC patients with(More)
BACKGROUND Liver stiffness measurement (LSM) using transient elastography has recently become available for the assessment of liver fibrosis. Whether LSM can predict the functional liver reserve in patients undergoing liver resection is not certain. AIM To correlate liver stiffness measurement (LSM) with indocyanine green (ICG) clearance test and liver(More)
  • 1